Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Original languageDanish
Publication date4. Jun 2018
Publication statusPublished - 4. Jun 2018
Event2018 ASCO Annual Meeting: Delivering discoveries: Expanding the reach of precision medicine - McCormick Place, Chicago , United States
Duration: 1. Jun 20185. Jun 2018


Conference2018 ASCO Annual Meeting
LocationMcCormick Place
CountryUnited States
Internet address

Cite this